Proteomics Research Blog

The Silent Sentinels: Understanding Toxicology in Modern Science and Drug Development

Authors: Katharina Schatz, Ronny Schmidt, Monique Eutebach

Toxicology has evolved far beyond traditional safety testing. Modern approaches combine advanced in vitro models, artificial intelligence, computational toxicology, and proteomics to identify toxicological risks earlier and more accurately than ever before.

Discover how predictive toxicology, biomarker discovery, organoids, and organ-on-chip technologies are transforming drug development, improving patient safety, and shaping the future of biomedical research.

Scientific overview of predictive toxicology and modern drug safety assessment, highlighting organoids, organ-on-chip platforms, human cell cultures, iPSC-derived tissues, biomarker discovery, proteomics, artificial intelligence, and high-throughput screening for toxicity prediction and pharmaceutical research

Evolution of Toxicology: From Traditional Testing to Predictive Human-Relevant Safety Assessment: Illustration of the shift from traditional toxicology toward predictive toxicology, highlighting organoids, organ-on-chip platforms, iPSC-derived tissues, proteomics, biomarker discovery, AI-driven toxicity prediction, and high-throughput screening for improved drug safety assessment and human-relevant pharmaceutical research.

Marfan Syndrome: Decoding Aortic Risk from Fibrillin Mutation to Precision Medicine

Authors: Katharina Schatz, Ronny Schmidt, Monique Eutebach

Marfan Syndrome is a hereditary connective tissue disorder and a leading genetic cause of thoracic aortic aneurysm and dissection. Once considered primarily a structural disease, it is now recognised as a complex molecular signalling disorder driven by dysregulated TGF-β pathways, extracellular matrix remodelling and oxidative stress.

Explore how emerging biomarkers, together with high-throughput proteomics and antibody microarrays, are enabling molecular risk stratification and advancing Precision Medicine in Marfan Syndrome.

Infographic illustrating the molecular pathogenesis and systemic manifestations of Marfan syndrome, showing FBN1 mutation, defective fibrillin-1, increased TGF-β signalling, extracellular matrix degradation, and major clinical features including aortic aneurysm, lens dislocation and skeletal abnormalities.

Molecular mechanisms and systemic manifestations of Marfan Syndrome: FBN1 mutations lead to defective fibrillin-1, dysregulated TGF-β signalling and extracellular matrix breakdown, driving aortic aneurysm formation and multisystem involvement affecting the cardiovascular, ocular, musculoskeletal and pulmonary systems.

The Parkinson’s Revolution: How Proteomics and Biomarkers Transform Diagnosis and Development of Disease-Modifying Therapies

Authors: Ronny Schmidt, Monique Eutebach

Parkinson’s Disease remains one of the most complex neurodegenerative disorders, driven by diverse molecular mechanisms and marked heterogeneity across patients. In this article, we explore how advances in proteomics and biomarker research are reshaping our understanding of this α-Synuclein pathology, improving diagnostic accuracy, and accelerating the development of disease-modifying therapies. Discover how Precision Medicine, molecular stratification, and innovative analytical technologies are paving the way toward earlier detection and truly targeted interventions in Parkinson’s Disease.

Key molecular and cellular hallmarks of Parkinson’s Disease reflect the multifactorial nature of neurodegeneration. α-Synuclein aggregation, neuroinflammation, mitochondrial dysfunction, oxidative stress, impaired proteostasis, and gut–brain axis involvement drive disease progression and define critical targets for biomarker discovery and precision therapy development.

Key molecular and cellular hallmarks of Parkinson’s Disease reflect the multifactorial nature of neurodegeneration: α-Synuclein aggregation, neuroinflammation, mitochondrial dysfunction, oxidative stress, impaired proteostasis, and gut–brain axis involvement drive disease progression and define critical targets for biomarker discovery and precision therapy development.

Stay tuned!

Sciomics Protomics Research Blog

At Sciomics, we are dedicated to advancing healthcare through proteomics research.
We are collaborating with research groups and big pharma, alongside our in-house biomarker research initiatives.
To make this research more accessible to you, we launched the Sciomics science blog!

Decoding Protein Complexity: The Fundamental Role of Post-Translational Modifications in Cellular Function and Disease

Authors: Henning Boekhoff, Jana S. Röder

Proteins are key players in cellular functions. They are encoded by their corresponding genes, but protein functions and activity are remarkably diverse and dynamic, largely due to post-translational modifications (PTMs). PTMs are covalent chemical changes to the side chains of amino acids that occur after protein synthesis, enhancing protein diversity across life forms from Archaea to Eukaryotes. This mechanism complements the complex network of proteomic regulation, greatly expanding upon gene expression, gene duplication, and alternative splicing. While the genome acts as a blueprint, providing the necessary information to build a functioning cell, the proteome is a complex structure that vastly extends beyond the blueprint’s scope.

Protein functions and activity are remarkably diverse and dynamic, largely due to post-translational modifications (PTMs). PTMs are covalent chemical changes to the side chains of amino acids that occur after protein synthesis, enhancing protein diversity across life forms from Archaea to Eukaryotes. This mechanism complements the complex network of proteomic regulation, greatly expanding upon gene expression, gene duplication, and alternative splicing.